Nexalin Technology (NXL) Gross Profit (2021 - 2026)
Nexalin Technology's quarterly Gross Profit came in at $13133.0 in Q1 2026, down 52.17% year-on-year from $27457.0 in Q1 2025, and down 91.29% quarter-over-quarter from $150866.0 in Q4 2025.
Nexalin Technology has reported Gross Profit for 6 years, with the latest figure at $13133.0 in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit fell 52.17% year-over-year to $13133.0; the trailing twelve-month figure through Mar 2026 stood at $225950.0 (up 150.86% YoY), and the FY2025 full-year result was $240274.0, up 81.85% from the prior year.
- Gross Profit for Q1 2026 stood at $13133.0, down from $150866.0 in the prior quarter.
- The five-year high for Gross Profit was $358025.0 in Q3 2022, with the low at $13133.0 in Q1 2026.
- Average Gross Profit over 5 years is $84043.6, with a median of $26166.0 recorded in 2023.
- Year-over-year, Gross Profit surged 667.24% in 2022 and slumped 94.37% in 2023.
- Tracing NXL's Gross Profit over 5 years: stood at $31557.0 in 2022, then tumbled by 51.5% to $15305.0 in 2023, then advanced by 28.61% to $19683.0 in 2024, then surged by 666.48% to $150866.0 in 2025, then slumped by 91.29% to $13133.0 in 2026.
- The last three Gross Profit figures came in at $13133.0 (Q1 2026), $150866.0 (Q4 2025), and $14201.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,133.00 |
| Mar 31, 2026 | 13,133.00 |
| Dec 31, 2025 | 150,866.00 |
| Dec 31, 2025 | 150,866.00 |
| Sep 30, 2025 | 14,201.00 |
| Sep 30, 2025 | 14,201.00 |
| Jun 30, 2025 | 47,750.00 |
| Jun 30, 2025 | 47,750.00 |
| Mar 31, 2025 | 27,457.00 |
| Mar 31, 2025 | 27,457.00 |
| Dec 31, 2024 | 19,683.00 |
| Dec 31, 2024 | 19,683.00 |
| Sep 30, 2024 | 23,337.00 |
| Sep 30, 2024 | 23,337.00 |
| Jun 30, 2024 | 19,593.00 |
| Jun 30, 2024 | 19,593.00 |
| Mar 31, 2024 | 69,515.00 |
| Mar 31, 2024 | 69,515.00 |
| Dec 31, 2023 | 15,305.00 |
| Dec 31, 2023 | 15,305.00 |
| Sep 30, 2023 | 20,140.00 |
| Sep 30, 2023 | 20,140.00 |
| Jun 30, 2023 | 26,166.00 |
| Jun 30, 2023 | 26,166.00 |
| Mar 31, 2023 | 23,450.00 |
| Mar 31, 2023 | 23,450.00 |
| Dec 31, 2022 | 31,557.00 |
| Dec 31, 2022 | 31,557.00 |
| Sep 30, 2022 | 358,025.00 |
| Sep 30, 2022 | 358,025.00 |
| Jun 30, 2022 | 291,256.00 |
| Jun 30, 2022 | 291,256.00 |
| Mar 31, 2022 | 277,307.00 |
| Mar 31, 2022 | 277,307.00 |
| Dec 31, 2021 | 25,005.00 |
| Dec 31, 2021 | 25,005.00 |
| Sep 30, 2021 | 46,664.00 |
| Sep 30, 2021 | 46,664.00 |